Works matching DE "RADIOPHARMACEUTICALS"

Results: 4100
    1

    The utility of <sup>68</sup>Ga-DOTATATE and <sup>18</sup>F-FDG PET/CT in predicting the response to tyrosine kinase inhibitors in patients with advanced medullary thyroid cancer.

    Published in:
    Thyroid Research, 2025, v. 18, n. 1, p. 1, doi. 10.1186/s13044-025-00250-x
    By:
    • Jager, Eline C.;
    • McNeil, James;
    • Papachristos, Alexander J.;
    • Sywak, Mark;
    • Sidhu, Stan B.;
    • Siddall, Rhonda;
    • Hoang, Jeremy;
    • Schembri, Geoffrey P.;
    • Tsang, Venessa H. M.;
    • Wijewardene, Ayanthi;
    • Tacon, Lyndal;
    • Robinson, Bruce;
    • Clifton-Bligh, Roderick J.;
    • Bullock, Martyn;
    • Brouwers, Adrienne H.;
    • Links, Thera P.;
    • Kruijff, Schelto;
    • Glover, Anthony R.;
    • Gild, Matti L.
    Publication type:
    Article
    2
    3
    4

    Comparison of <sup>64</sup>Cu-DOTA-PSMA-3Q and <sup>64</sup>Cu-NOTA-PSMA-3Q utilizing NOTA and DOTA as bifunctional chelators in prostate cancer: preclinical assessment and preliminary clinical PET/CT imaging.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 8, p. 2792, doi. 10.1007/s00259-025-07131-3
    By:
    • Liu, Huanhuan;
    • Zhang, Xiaojun;
    • Zhang, Jingfeng;
    • Pan, Yue;
    • Wen, Hui;
    • Xu, Xiaodan;
    • Wu, Shina;
    • Wang, Yuan;
    • Zhang, Cong;
    • Ma, Guangyu;
    • Liu, Yachao;
    • Wang, Ruimin;
    • Zhang, Jinming
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11
    12

    Changes of Prostate-Specific Membrane Antigen-Radioligand Uptake on PET with Systemic Therapy in Patients with Metastatic Renal Cell Carcinoma.

    Published in:
    Cancers, 2025, v. 17, n. 11, p. 1736, doi. 10.3390/cancers17111736
    By:
    • Kunte, Sophie Carina;
    • Holzgreve, Adrien;
    • Unterrainer, Marcus;
    • Zahner, Josef;
    • Schmid, Hans Peter;
    • Schöll, Magdalena;
    • Blajan, Iulia;
    • Sheikh, Gabriel T.;
    • Mehrens, Dirk;
    • Casuscelli, Jozefina;
    • Tamalunas, Alexander J.;
    • Werner, Rudolf A.;
    • Stief, Christian G.;
    • Staehler, Michael;
    • Unterrainer, Lena M.
    Publication type:
    Article
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26

    The role of PSMA-based radioligand therapy in hormone-sensitive prostate cancer.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 7, p. 2723, doi. 10.1007/s00259-025-07083-8
    By:
    • Laudicella, Riccardo;
    • Bauckneht, Matteo;
    • Burger, Irene A;
    • Cacciola, Alberto;
    • Fanti, Stefano;
    • Farolfi, Andrea;
    • Ficarra, Vincenzo;
    • Iagaru, Andrei;
    • Liberini, Virginia;
    • Pergolizzi, Stefano;
    • Santo, Giulia;
    • Virgolini, Irene;
    • Minutoli, Fabio;
    • Baldari, Sergio
    Publication type:
    Article
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36

    An Alpha Edge?

    Published in:
    Oncology (08909091), 2012, v. 26, n. 4, p. 345
    By:
    • SILBERSTEIN, EDWARD B.
    Publication type:
    Article
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48

    Selective Chelation of the Exotic Meitner‐Auger Emitter Mercury‐197 m/g with Sulfur‐Rich Macrocyclic Ligands: Towards the Future of Theranostic Radiopharmaceuticals.

    Published in:
    Chemistry - A European Journal, 2023, v. 29, n. 21, p. 1, doi. 10.1002/chem.202203815
    By:
    • Randhawa, Parmissa;
    • Gower‐Fry, K. Lexi;
    • Stienstra, Cailum M. K.;
    • Tosato, Marianna;
    • Chen, Shaohuang;
    • Gao, Yang;
    • McDonagh, Anthony W.;
    • Di Marco, Valerio;
    • Radchenko, Valery;
    • Schreckenbach, Georg;
    • Ramogida, Caterina F.
    Publication type:
    Article
    49
    50